Resultados de procura - Pascal Burtin

  • Mostrando 1 - 5 Resultados de 5
Limitar resultados
  1. 1
    The safety of endoscopic sphincterotomy in patients receiving antiplatelet agents – a case–control study

    The safety of endoscopic sphincterotomy in patients receiving antiplatelet agents – a case–control study por Nadeem Hussain, Raed Alsulaiman, Pascal Burtin, Youssef Toubouti, Elham Rahme, J.‐F. Boivin, Alan Barkun

    Publicado 2006
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  2. 2
    Adenoma and advanced neoplasia detection rates increase from 45 years of age

    Adenoma and advanced neoplasia detection rates increase from 45 years of age por David Karsenti, Gaëlle Tharsis, Pascal Burtin, Franck Venezia, Gilles Tordjman, Agnès Gillet, Joëlle Samama, Karine Nahon-Uzan, Philippe Cattan, Maryan Cavicchi

    Publicado 2018
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  3. 3
    Relationship between 5-fluorouracil (5-FU) dose intensity and therapeutic response in patients with advanced colorectal cancer receiving infusional therapy containing 5-FU

    Relationship between 5-fluorouracil (5-FU) dose intensity and therapeutic response in patients with advanced colorectal cancer receiving infusional therapy containing 5-FU por Érick Gamelin, E Danquechin‐Dorval, Y. Dumesnil, P. Maillart, Marie-Josèphe Goudier, Pascal Burtin, R. Delva, Alain Lortholary, Paul Gesta, F Larra

    Publicado 1996
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  4. 4
    Survival, safety, and prognostic factors for outcome with Regorafenib in patients with metastatic colorectal cancer refractory to standard therapies: results from a multicenter study (REBECCA) nested within a compassionate use program

    Survival, safety, and prognostic factors for outcome with Regorafenib in patients with metastatic colorectal cancer refractory to standard therapies: results from a multicenter stu... por Antoine Adenis, Christelle de la Fouchardière, Bernard Paule, Pascal Burtin, David Tougeron, Jennifer Wallet, Louis-Marie Dourthe, Pierre-Luc Etienne, Laurent Mineur, Stéphanie Clisant, Jean-Marc Phélip, Andrew Kramar, Thierry André

    Publicado 2016
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  5. 5
    Post-first-line FOLFOX chemotherapy for grade 3 neuroendocrine carcinoma

    Post-first-line FOLFOX chemotherapy for grade 3 neuroendocrine carcinoma por Julien Hadoux, David Malka, David Planchard, Jean–Yves Scoazec, Caroline Caramella, J. Guigay, Valérie Boige, Sophie Leboulleux, Pascal Burtin, A. Berdelou, Yohann Loriot, Pierre Duvillard, C. Chougnet, Désirèe Deandreis, Martin Schlumberger, Isabelle Borget, Michel Ducreux, Éric Baudin

    Publicado 2015
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: